|

FOLFIRI (Fluorouracil (5-FU), leucovorin, irinotecan) Clinical Trials

2 actively recruiting trials across 1 location

Pipeline

Phase 2: 1Phase 1/2: 1

Top Sponsors

  • Chang Gung Memorial Hospital1
  • AstraZeneca1

Indications

  • Cancer2
  • Liver Disease1
  • CRC1
  • Liver Cancer1
  • Metastatic Colorectal Cancer1

Other1 trial

The Phase 1b/IIa, Open-label, Dose Escalation and Dose Expansion to Evaluate Safety, Tolerability, and Preliminary Efficacy of the Combination of HCB101, Cetuximab/Bevacizumab, and FOLFOX/FOLFIRI in Advanced or Metastatic Colorectal Cancer
Phase 1/2

Scottsdale, Arizona1 trial

A Study of Novel Study Interventions and Combinations in Participants With Colorectal Cancer

Research Site

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.